PROCTO-GLYVENOL

This brand name is authorized in Brazil, Cyprus, Ecuador, Hong Kong SAR China, Israel, Lithuania, Malta, Mexico, Poland, Romania, Turkey.

Active ingredients

The drug PROCTO-GLYVENOL contains a combination of these active pharmaceutical ingredients (APIs):

1	Tribenoside UNII Z7N0Y673NU - TRIBENOSIDE
	Read more about Tribenoside
2	Lidocaine hydrochloride monohydrate UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C05AD01	Lidocaine	C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AD Local anesthetics
Discover more medicines within C05AD01
C05AX05	Tribenoside	C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
Discover more medicines within C05AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510617110058017, 510617110058117
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.827-08-07
HK	Department of Health Drug Office	57779, 58773
IL	מִשְׂרַד הַבְּרִיאוּת	579, 580
LT	Valstybinė vaistų kontrolės tarnyba	1008527, 1013222
MT	Medicines Authority	MA1177/01101
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	77464, 77465
PL	Rejestru Produktów Leczniczych	100055140, 100055156, 100257569, 100265801, 100265818, 100270972, 100271718, 100284170, 100284187, 100298781, 100302436, 100326827, 100327880, 100330993, 100341063, 100351268, 100353385, 100370797, 100370805, 100387332, 100395171, 100395283, 100410999, 100411786, 100419612, 100419760, 100419782, 100425660, 100425676, 100427758, 100432216, 100441630, 100462510, 100463386
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57302002, W57303002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699559330014, 8699559890037